Lotus BioScience Ventures

investment firm

About

Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.

  • Hong Kong,Hong Kong Island,Hong Kong

Details

Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
6
0
Lotus BioScience Ventures has made 6 investments. Their most recent investment was on Sep 23, 2008, when Humanigen raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 23, 2008 Humanigen
Series D $20M Biopharma
Series D $42.60M Biotechnology
Private Equity(PE) $71.30M Biotechnology
Mar 16, 2005 Humanigen
Series B $20M Biopharma
Series B $70M Biopharma

Exits

Lotus BioScience Ventures has had 5 exits. Lotus BioScience Ventures most notable exits include Humanigen ,   Nereus Pharmaceuticals

Date Company Name Exit Type Industry
Aug 7, 2017 Humanigen IPO Biopharma Detail
Jan 1, 2012 Nereus Pharmaceuticals M&A Biotechnology Detail
Oct 17, 2011 Anadys Pharmaceuticals M&A Biotechnology Detail
Aug 4, 2009 Infinity Pharmaceuticals IPO Biopharma Detail
Feb 19, 2004 Dynavax Technologies IPO Biopharma Detail